Murat Eser Akyurek

Nigella sativa black cumin oil (BCO) exhibits well-documented anti-inflammatory and antioxidant properties; however, the impact of extraction-related compositional variation on its cellular and molecular effects in stem cell systems remains insufficiently characterized. This study investigated the effects of cold-pressed (CP) and supercritical CO ₂ (ScCO ₂ )-extracted BCO on the viability, inflammatory response and angiogenic potential of adipose-derived mesenchymal stem cells (ASCs). The oil composition and antioxidant activity were assessed using GC/MS and DPPH assays, respectively. ASCs were treated with different volumes of BCO, and cell viability was evaluated at 24, 48 and 72 h using the MTT assay. Anti-inflammatory effects were evaluated by real-time PCR analysis of IL6 and IL10 mRNA expression, while angiogenesis-related molecular responses were evaluated based on VEGF mRNA expression. Both CP and ScCO ₂ -extracted BCO significantly increased ASC viability in a volume-dependent manner, with the highest viability consistently observed at 100 µl (P < 0.05). Treatment with 50 µl and 100 µl of either oil significantly reduced IL6 expression and concomitantly increased IL10 expression at 24 and 48 h (P < 0.05). VEGF expression was also significantly up-regulated at these time points, with ScCO ₂ -extracted BCO inducing a more pronounced and sustained angiogenic response (P < 0.05). These findings indicate that BCO enhances ASC via­bility and molecular responses in a volume-dependent manner, while differences associated with extraction-related compositional variation may modulate inflammation- and angiogenesis-related molecular signalling in ASCs.

Objective: This study aims to evaluate the effects of hemp seed oil (HSO) on adipose-derived stem cells (ASCs) to enhance tissue repair, regulate inflammation, and promote angiogenesis. Background: HSO, rich in bioactive compounds, was obtained via cold press (CP) and supercritical carbon dioxide (ScCO₂) methods to assess its effects on cytokines and vascular endothelial growth factor (VEGF) in ASCs. Methods: Chemical composition were assessed via gas chromatography-mass spectrometry (GC–MS) and antioxidant activity was determined by measuring the % radical scavenging activity (RSA) with 1,1-diphenyl-2-picrylhydrazyl (DPPH). ASCs were treated with HSO and, cell viability was measured at 24, 48, and 72 h using the methyl thiazolyl tetrazolium (MTT). Gene expression of interleukin-6 (IL-6), interleukin-10 (IL-10), and VEGF was quantified by real-time PCR. Results: The CP-fixed HSO had higher linoleic (48.48%) and oleic acid (29.33%) content than ScCO₂-extracted HSO. Phenolic content and antioxidant activity were greater in CP-fixed HSO [57.85 mgGAE (mgGallic Acid Equivalent)/g, 68.8%] than in ScCO_2-extracted HSO (58.5 mgGAE/g, 19.9%). Cell viability increased significantly with 75 and 100 µL of CP-fixed HSO at 48 and 72 h (p < 0.05). CP-fixed HSO up-regulated IL-10 and reduced IL-6 at 24 and 48 h (p < 0.05), while also increasing VEGF with 50 and 100 µL at 24 and 48 h (p < 0.05). ScCO₂-extracted HSO primarily up-regulated IL-10 but had limited effects on IL-6 and VEGF. Conclusions: CP-fixed HSO had superior phenolic content, antioxidant activity, and enhanced ASC viability, anti-inflammatory effects, and angiogenesis, suggesting strong therapeutic potential for stem cell use.

Purpose. In this study, the expression levels of METTL3, METTL14; and WTAP genes involved in the N6-methyladenosine (m6A) pathway, regulating cellular processes including cell renewal, differentiation, invasion; and apoptosis, were investigated in duodenal tissue after sleeve gastrectomy (SG). Material and Methods: Duodenal biopsies were obtained from 24 obese patients before (BG) and 6 months after (AG) sleeve gastrectomy. Pathological evaluation was performed by H&E staining. Expression levels of METTL14, METTL3, and WTAP genes were analysed by Real-Time PCR. Results: The METTL14 gene was significantly increased after surgery (BG-AG Median (Q1-Q3): 0.36 [0.07-1.52]-9.83 [0.20-68.12]). METTL3 (BG-AG Median (Q1-Q3): 0.49 [0.32-0.84]-0.67 [0.36-20.5]) and WTAP (BG-AG Median (Q1-Q3): 0.95 [0.17-7.65]-5.54 [2.34-66.07]) gene expressions were not altered. However, a strong positive (r=0.692) and significant relationship was found between METTL3 and WTAP. Chronic inflammation 81.32 %, intestinal metaplasia 10.54 %, activity 68.88 %, atrophy 5.32 %. No malignant findings were detected. Conclusion: For the first time, we demonstrated that sleeve gastrectomy may increase the expression of the METTL14 gene involved in the m6A-methyladenosine pathway in duodenum. This alteration may lead to gastrointestinal tract diseases.

Epigenetic modifications are known to be effective in the severity and mortality rate of SARS-CoV-2 infection. N6-methyladenosin (m6A) is a posttranscripti